The analyses and visuals on this site are for informational purposes only and do not constitute investment advice.

© 2026 Datafin Financial Data Analysis Systems. All rights reserved. · v2.0

Privacy PolicyTerms of UseCookie Policy

CRBU FINANCIAL STATEMENTS

Caribou Biosciences Inc — balance sheet, income statement and cash flow trends

CRBUCaribou Biosciences Inc

🇺🇸 USA · NASDAQ · Healthcare · Biotechnology

Value itDuel
PriceFinancialsPeers

Income Statement

Quarterly progression — trailing-twelve-month values
RevenueNet Income to Owners
-100 M0202120222023202420252026

Profit Funnel

Q2 2026 · TTM
Revenue10 M $Gross Profit-13 M $ · -130%Operating Income-109.5 M $ · -1091%Pre-tax Income-104 M $ · -1036%Net Income to Owners-103.4 M $ · -1030%

Percentages are relative to revenue.

Key Figures

YoY change
Revenue10 M $+10.0%
Gross Profit-13 M $—
Operating Income-109.5 M $—
EBITDA-104.1 M $—
Net Income to Owners-103.4 M $—

No peer data is available for this stock.

Balance Sheet

Quarterly period-end values
Total AssetsTotal LiabilitiesEquity
0200 M400 M202120222023202420252026

Capital Structure

Q2 2026
Total Assets142.8 M
  • Equity98.1 M $69%
  • Current Liabilities18 M $13%
  • Long-term Liabilities26.7 M $19%

Key Figures

YoY change
Total Assets142.8 M $-35.4%
Total Liabilities44.7 M $-18.4%
Total Equity98.1 M $-40.9%
Cash & ST Investments112.3 M $-38.9%
Total Debt26.7 M $+3.1%
Net Debt461 K $-29.1%

No peer data is available for this stock.

Cash Flow Statement

Quarterly progression — trailing-twelve-month values
Operating Cash FlowCapital ExpendituresFree Cash Flow
-150 M-100 M-50 M0202120222023202420252026

Cash Flow Bridge

Q2 2026 · TTM
-100 M-50 M0-95.8 M $Operating71.7 M $Investing25 M $Financing947 K $Net Change

Key Figures

YoY change
Operating Cash Flow-95.8 M $—
Capital Expenditures404 K $-84.8%
Free Cash Flow-95.8 M $—
Dividends Paid——

No peer data is available for this stock.

Amounts are in the company’s reporting currency. Peer comparison tables use ratio-based metrics so currency differences do not distort the picture.

Go deeper on CRBU

Run a DCF valuation

Full DCF model with editable assumptions

Start a head-to-head duel

Compare two stocks metric by metric

Filter in the stock screener

Build your own universe with 400+ metrics

Data on this page refreshes once per day. Price data as of Sep 3, 26. This content is for informational purposes only and is not investment advice.